$105.02
-3.4-3.13%
Last update: 3:41 PM
15 minutes delayed
ArcBest
ARCBNASDAQ
want to know what
the Bulls & Bears Say?
ArcBest (NASDAQ:ARCB) Stock, Analyst Ratings, Price Targets, Forecasts
ArcBest Corp has a consensus price target of $128.81 based on the ratings of 61 analysis. The 3 most-recent analyst ratings were released by JP Morgan, Morgan Stanley, and Wells Fargo on July 9, 2024, July 8, 2024, and June 7, 2024, respectively. With an average price target of $147.67 between JP Morgan, Morgan Stanley, and Wells Fargo, there's an implied 40.61% upside for ArcBest Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Morgan Stanley
Wells Fargo
Stifel
TD Cowen
1calculated from analyst ratings
Analyst Ratings for ArcBest
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | 20.94% | JP Morgan | Brian Ossenbeck | $145 → $127 | Downgrade | Overweight → Neutral | Get Alert |
| 07/08/2024 | Buy Now | 67.6% | Morgan Stanley | Ravi Shanker | $180 → $176 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 33.31% | Wells Fargo | Christian Wetherbee | → $140 | Initiates | → Overweight | Get Alert |
| 05/15/2024 | Buy Now | 42.84% | Stifel | J. Bruce Chan | $159 → $150 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | 40.93% | TD Cowen | Jason Seidl | $177 → $148 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | 4.75% | B of A Securities | Ken Hoexter | $143 → $110 | Maintains | Underperform | Get Alert |
| 05/01/2024 | Buy Now | 19.98% | UBS | Thomas Wadewitz | $150 → $126 | Maintains | Neutral | Get Alert |
| 05/01/2024 | Buy Now | 38.08% | JP Morgan | Brian Ossenbeck | $164 → $145 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | 36.17% | B of A Securities | Ken Hoexter | $141 → $143 | Maintains | Underperform | Get Alert |
| 04/11/2024 | Buy Now | 41.88% | Goldman Sachs | Jordan Alliger | $133 → $149 | Maintains | Neutral | Get Alert |
| 04/09/2024 | Buy Now | 56.17% | JP Morgan | Brian Ossenbeck | $168 → $164 | Maintains | Overweight | Get Alert |
| 03/11/2024 | Buy Now | 59.98% | JP Morgan | Brian Ossenbeck | → $168 | Initiates | → Overweight | Get Alert |
| 02/16/2024 | Buy Now | 42.84% | UBS | Thomas Wadewitz | $119 → $150 | Maintains | Neutral | Get Alert |
| 02/07/2024 | Buy Now | 66.64% | Morgan Stanley | Ravi Shanker | $155 → $175 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | 51.41% | Stifel | J. Bruce Chan | $153 → $159 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | 95.21% | Stephens & Co. | Jack Atkins | $165 → $205 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | 40.93% | Deutsche Bank | Ben Mohr | → $148 | Initiates | → Buy | Get Alert |
| 01/10/2024 | Buy Now | 45.69% | Stifel | J. Bruce Chan | $136 → $153 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | 13.32% | UBS | Thomas Wadewitz | $110 → $119 | Maintains | Neutral | Get Alert |
| 10/30/2023 | Buy Now | 29.51% | Stifel | J. Bruce Chan | $132 → $136 | Maintains | Buy | Get Alert |
| 10/30/2023 | Buy Now | 38.08% | Morgan Stanley | Ravi Shanker | $135 → $145 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | 2.84% | B of A Securities | Ken Hoexter | $110 → $108 | Maintains | Underperform | Get Alert |
| 10/04/2023 | Buy Now | 23.79% | Citigroup | Christian Wetherbee | $137 → $130 | Maintains | Buy | Get Alert |
| 09/18/2023 | Buy Now | 4.75% | UBS | Thomas Wadewitz | → $110 | Initiates | → Neutral | Get Alert |
| 08/21/2023 | Buy Now | — | Wolfe Research | Scott Group | — | Upgrade | Peer Perform → Outperform | Get Alert |
| 08/01/2023 | Buy Now | 28.55% | Morgan Stanley | Ravi Shanker | $125 → $135 | Maintains | Overweight | Get Alert |
| 08/01/2023 | Buy Now | 27.6% | Stifel | J. Bruce Chan | $125 → $134 | Maintains | Buy | Get Alert |
| 07/31/2023 | Buy Now | 30.46% | Citigroup | Christian Wetherbee | $118 → $137 | Maintains | Buy | Get Alert |
| 07/31/2023 | Buy Now | 28.55% | Morgan Stanley | Ravi Shanker | $125 → $135 | Maintains | Overweight | Get Alert |
| 07/31/2023 | Buy Now | 11.41% | Goldman Sachs | Jordan Alliger | $105 → $117 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 20.94% | Credit Suisse | Ariel Rosa | $104 → $127 | Downgrade | Outperform → Neutral | Get Alert |
| 07/06/2023 | Buy Now | 19.03% | Morgan Stanley | Ravi Shanker | $136 → $125 | Maintains | Overweight | Get Alert |
| 06/30/2023 | Buy Now | 12.36% | Citigroup | Christian Wetherbee | $110 → $118 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 2.84% | TD Cowen | Jason Seidl | $119 → $108 | Maintains | Outperform | Get Alert |
| 06/12/2023 | Buy Now | 4.75% | Jefferies | Stephanie Moore | → $110 | Initiates | → Buy | Get Alert |
| 05/01/2023 | Buy Now | 7.6% | Stifel | J. Bruce Chan | $114 → $113 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | 2.84% | Credit Suisse | Ariel Rosa | → $108 | Reiterates | → Outperform | Get Alert |
| 05/01/2023 | Buy Now | -13.35% | B of A Securities | Ken Hoexter | $101 → $91 | Downgrade | Neutral → Underperform | Get Alert |
| 04/04/2023 | Buy Now | 29.51% | Morgan Stanley | Ravi Shanker | $138 → $136 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 10.46% | Citigroup | Christian Wetherbee | $90 → $116 | Maintains | Buy | Get Alert |
| 02/13/2023 | Buy Now | 31.41% | Morgan Stanley | Ravi Shanker | → $138 | Reiterates | → Overweight | Get Alert |
| 02/06/2023 | Buy Now | -4.78% | Credit Suisse | Ariel Rosa | $90 → $100 | Maintains | Outperform | Get Alert |
| 01/11/2023 | Buy Now | 31.41% | Morgan Stanley | Ravi Shanker | $139 → $138 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | 32.36% | Morgan Stanley | Ravi Shanker | $140 → $139 | Maintains | Overweight | Get Alert |
| 11/02/2022 | Buy Now | -12.39% | Credit Suisse | Ariel Rosa | $87 → $92 | Maintains | Outperform | Get Alert |
| 10/07/2022 | Buy Now | -14.3% | Citigroup | Christian Wetherbee | $94 → $90 | Maintains | Buy | Get Alert |
| 09/09/2022 | Buy Now | -0.01% | Credit Suisse | Ariel Rosa | $112 → $105 | Maintains | Outperform | Get Alert |
| 08/02/2022 | Buy Now | 28.55% | Stifel | J. Bruce Chan | $143 → $135 | Maintains | Buy | Get Alert |
| 08/01/2022 | Buy Now | 14.27% | Stephens & Co. | Jack Atkins | $105 → $120 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 0.94% | Credit Suisse | Ariel Rosa | $102 → $106 | Maintains | Outperform | Get Alert |
| 06/28/2022 | Buy Now | -2.87% | Credit Suisse | Ariel Rosa | → $102 | Initiates | → Outperform | Get Alert |
| 05/18/2022 | Buy Now | 33.31% | Morgan Stanley | Ravi Shanker | $145 → $140 | Maintains | Overweight | Get Alert |
| 04/08/2022 | Buy Now | -27.63% | B of A Securities | Ken Hoexter | → $76 | Downgrade | Buy → Neutral | Get Alert |
| 03/09/2022 | Buy Now | -0.97% | B of A Securities | Ken Hoexter | $117 → $104 | Maintains | Buy | Get Alert |
| 02/02/2022 | Buy Now | 5.7% | Goldman Sachs | Jordan Alliger | $108 → $111 | Maintains | Neutral | Get Alert |
| 11/09/2021 | Buy Now | 33.31% | Morgan Stanley | Ravi Shanker | — | Maintains | Overweight | Get Alert |
| 10/19/2021 | Buy Now | -1.92% | B of A Securities | Ken Hoexter | — | Maintains | Buy | Get Alert |
| 10/05/2021 | Buy Now | -4.78% | Truist Securities | Stephanie Benjamin | — | Maintains | Buy | Get Alert |
| 10/04/2021 | Buy Now | -4.78% | Morgan Stanley | Ravi Shanker | — | Maintains | Overweight | Get Alert |
| 09/30/2021 | Buy Now | 9.51% | Cowen & Co. | Jason Seidl | — | Maintains | Outperform | Get Alert |
| 07/14/2021 | Buy Now | -9.54% | Citigroup | Christian Wetherbee | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for ArcBest (ARCB) stock?
The latest price target for ArcBest (NASDAQ:ARCB) was reported by JP Morgan on July 9, 2024. The analyst firm set a price target for $127.00 expecting ARCB to rise to within 12 months (a possible 20.94% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ArcBest (ARCB)?
The latest analyst rating for ArcBest (NASDAQ:ARCB) was provided by JP Morgan, and ArcBest downgraded their neutral rating.
When was the last upgrade for ArcBest (ARCB)?
The last upgrade for ArcBest Corp happened on August 21, 2023 when Wolfe Research raised their price target to N/A. Wolfe Research previously had a peer perform for ArcBest Corp.
When was the last downgrade for ArcBest (ARCB)?
The last downgrade for ArcBest Corp happened on July 9, 2024 when JP Morgan changed their price target from $145 to $127 for ArcBest Corp.
When is the next analyst rating going to be posted or updated for ArcBest (ARCB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ArcBest, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ArcBest was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating ArcBest (ARCB) correct?
While ratings are subjective and will change, the latest ArcBest (ARCB) rating was a downgraded with a price target of $145.00 to $127.00. The current price ArcBest (ARCB) is trading at is $105.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.